Literature DB >> 17981064

Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease.

Eve A Roberts1, Brian H Robinson, Suyun Yang.   

Abstract

Structural changes in hepatocellular mitochondria are characteristic of Wilson disease (WD). Features include variability in size and shape, increased density of matrix, discreet inclusions, and cystic dilatation of the cristae. We examined the functional basis for these mitochondrial changes in the toxic milk (tx-j) mouse model for WD. Its normal syngeic strain, C3H, served as control. Hepatic histology was near-normal in tx-j mice at 3-4-months-old and showed mild inflammation and steatosis at 6-months-old. Transmission electron microscopy showed typical mitochondrial abnormalities, specifically cystic dilatation of tips of cristae, in 3, 4, and 6-month-old tx-j mice and none in normal 3-month-old C3H mice. Citrate synthase (CS) activity was initially lower in tx-j mice than age-matched controls but increased over the first 6 months such that it was significantly greater at 5 and 6-months-old (p<0.003). No evidence for hepatic mtDNA depletion was found by long-PCR analysis. NB-PAGE showed preservation of all complexes in the oxidative-phosphorylation chain except complex IV which declined markedly from 5-months-old onwards. Hepatic complex IV activity was significantly decreased in 5-month-old tx-j mice (p<0.04). Expression of mitochondrial transfer factor A (TFAM) mRNA declined progressively in 6-8-month-old tx-j mice; immunodetectable protein levels declined in parallel. Expression of mtSSB mRNA was uniformly low in tx-j mice from 1-8-months-old. Levels of two mitochondrial antioxidant proteins capable of binding copper, thioredoxin-2 and peroxiredoxin-3, rose over the first 6 months of life. Mitochondrial changes occur early in WD and reflect complex, probably oxidative, injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981064     DOI: 10.1016/j.ymgme.2007.08.127

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  29 in total

1.  Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.

Authors:  A Moores; Susan Fox; Anthony Lang; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Bone demineralisation in a large cohort of Wilson disease patients.

Authors:  Karl Heinz Weiss; Mart Van de Moortele; Daniel Nils Gotthardt; Jan Pfeiffenberger; Jessica Seessle; Elena Ullrich; Evelien Gielen; Herman Borghs; Els Adriaens; Wolfgang Stremmel; Wouter Meersseman; Steven Boonen; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2015-02-07       Impact factor: 4.982

3.  The plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cells.

Authors:  Pieter Spincemaille; Gursimran Chandhok; Benjamin Newcomb; Jef Verbeek; Kim Vriens; Andree Zibert; Hartmut Schmidt; Yusuf A Hannun; Jos van Pelt; David Cassiman; Bruno P A Cammue; Karin Thevissen
Journal:  Biochim Biophys Acta       Date:  2014-03-13

4.  Microbial peptide de-coppers mitochondria: implications for Wilson disease.

Authors:  Stephen G Kaler
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

5.  Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Authors:  Josef Lichtmannegger; Christin Leitzinger; Ralf Wimmer; Sabine Schmitt; Sabine Schulz; Yaschar Kabiri; Carola Eberhagen; Tamara Rieder; Dirk Janik; Frauke Neff; Beate K Straub; Peter Schirmacher; Alan A DiSpirito; Nathan Bandow; Bipin S Baral; Andrew Flatley; Elisabeth Kremmer; Gerald Denk; Florian P Reiter; Simon Hohenester; Friedericke Eckardt-Schupp; Norbert A Dencher; Jerzy Adamski; Vanessa Sauer; Christoph Niemietz; Hartmut H J Schmidt; Uta Merle; Daniel Nils Gotthardt; Guido Kroemer; Karl Heinz Weiss; Hans Zischka
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

6.  Golgi-Dependent Copper Homeostasis Sustains Synaptic Development and Mitochondrial Content.

Authors:  Cortnie Hartwig; Gretchen Macías Méndez; Shatabdi Bhattacharjee; Alysia D Vrailas-Mortimer; Stephanie A Zlatic; Amanda A H Freeman; Avanti Gokhale; Mafalda Concilli; Erica Werner; Christie Sapp Savas; Samantha Rudin-Rush; Laura Palmer; Nicole Shearing; Lindsey Margewich; Jacob McArthy; Savanah Taylor; Blaine Roberts; Vladimir Lupashin; Roman S Polishchuk; Daniel N Cox; Ramon A Jorquera; Victor Faundez
Journal:  J Neurosci       Date:  2020-11-18       Impact factor: 6.167

Review 7.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

Review 8.  The mitochondrion: a central architect of copper homeostasis.

Authors:  Zakery N Baker; Paul A Cobine; Scot C Leary
Journal:  Metallomics       Date:  2017-11-15       Impact factor: 4.526

Review 9.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

10.  Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.

Authors:  Valentina Medici; Dorothy A Kieffer; Noreene M Shibata; Harpreet Chima; Kyoungmi Kim; Angela Canovas; Juan F Medrano; Alma D Islas-Trejo; Kusum K Kharbanda; Kristin Olson; Ruijun J Su; Mohammad S Islam; Raisa Syed; Carl L Keen; Amy Y Miller; John C Rutledge; Charles H Halsted; Janine M LaSalle
Journal:  Epigenetics       Date:  2016-09-09       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.